Evidence map›Paper›PMID 37520972›Full record

ArticleHeliyon2023

Microbial degradation and transformation of PPCPs in aquatic environment: A review.

Mathiyazhagan Narayanan, Sabariswaran Kandasamy, Jintae Lee, Selvaraj Barathi

Abstract read
In one paragraph

Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Design of FeMolecules (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mathiyazhagan NarayananDivision of Research and Innovations, Department of Biotechnology, Saveetha School of Engineering, Saveetha Institute of Medical and Technical Science, Chennai, 602 105, Tamil Nadu, India.
Sabariswaran KandasamyDepartment of Biotechnology, PSGR Krishnammal College for Women, Peelamedu, Coimbatore, 641004, India.
Jintae LeeSchool of Chemical Engineering, Yeungnam University, Gyeongsan, 38541, Republic of Korea.
Selvaraj BarathiSchool of Chemical Engineering, Yeungnam University, Gyeongsan, 38541, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Pharmaceuticals and Personal Care Products (PPCPs) presence at harmful levels has been identified in aquatic ecosystems all over the world. Currently, PPCPs are more common in aquatic regions and have been discovered to be extremely harmful to aquatic creatures. Waste-water treatment facilities are the primary cause of PPCPs pollution in aquatic systems due to their limited treatment as well as the following the release of PPCPs. The degree of PPCPs elimination is primarily determined by the method applied for the remediation. It must be addressed in an eco-friendly manner in order to significantly improve the environmental quality or, at the very least, to prevent the spread as well as effects of toxic pollutants. However, when compared to other methods, environmentally friendly strategies (biological methods) are less expensive and require less energy. Most biological methods under aerobic conditions have been shown to degrade PPCPs effectively. Furthermore, the scientific literature indicates that with the exception of a few extremely hydrophobic substances, biological degradation by microbes is the primary process for the majority of PPCPs compounds. Hence, this review discusses about the optimistic role of microbe concerned in the degradation or transformation of PPCPs into non/less toxic form in the polluted environment. Accordingly, more number of microbial strains has been implicated in the biodegradation/transformation of harmful PPCPs through a process termed as bioremediation and their limitations.

Indexed as

BiodegradationConversion pathwaysMetabolic processMicrobesPPCPs

Identifiers

PMID37520972
PMCPMC10382289

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.